Ligand Pharmaceuticals Incorporated Stock Performance
as on December 3, 2025 at 10:40 pm IST
Day's Low
Day's High
$193.73$197
0.33%
Downside
1.35%
Upside
52 Week's Low
52 Week's High
$93.58$212.4951.85%
Downside
9.32%
Upside
Ligand Pharmaceuticals Incorporated share price movements today
- Previous Close
- $195.10
- Open
- $195.92
- Volume
- 79.2K
- Day's Low - High
- $193.73 - $197
- 52 Week Low - High
- $93.58 - $212.49
Ligand Pharmaceuticals Incorporated Historical Returns
- 1 Month Return
- + 2.02 %
- 3 Month Return
- + 17.15 %
- 1 Year Return
- + 62.68 %
- 3 Year Return
- + 168.51 %
- 5 Year Return
- + 128.51 %
Ligand Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators
Check Ligand Pharmaceuticals Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9B
EPS (TTM)
7.6229
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.03%
PE Ratio (TTM)
86.77
Industry PE ratio
-0.3968729641693811
PEG Ratio
1.5271
EBITDA
63.0M
Revenue (TTM)
251.2M
Profit Margin
19.34%
Return On Equity TTM
5.42%
Ligand Pharmaceuticals Incorporated Stock Valuation
Track how Ligand Pharmaceuticals Incorporated P/E has moved over time to understand its valuation trends.
Ligand Pharmaceuticals Incorporated in the last 5 years
Lowest (9.67x)
December 31, 2023
Industry (-0.40x)
December 3, 2025
Today (86.77x)
December 3, 2025
Highest (35.40x)
September 30, 2025
Today’s Price to Earnings Ratio: 86.77x
Ligand Pharmaceuticals Incorporated vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ligand Pharmaceuticals Incorporated with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.9B | 128.51% | 86.77 | 19.34% | |
| BUY | $44.1B | 422.91% | -16.34 | -264.83% | |
| BUY | $60.1B | 254.45% | 1420.5 | 1.36% | |
| BUY | $109.1B | 90.92% | 29.93 | 31.35% | |
| BUY | $79.5B | 48.75% | 17.98 | 32.13% |
Stock Returns calculator for Ligand Pharmaceuticals Incorporated Stock including INR - Dollar returns
The Ligand Pharmaceuticals Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ligand Pharmaceuticals Incorporated investment value today
Current value as on today
₹1,68,575
Returns
₹68,575
(+68.58%)
Returns from Ligand Pharmaceuticals Incorporated Stock
₹62,070 (+62.07%)
Dollar Returns*
₹6,506 (+6.51%)
Analyst Recommendation on Ligand Pharmaceuticals Incorporated Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ligand Pharmaceuticals Incorporated. Average target price of $237.5
Ligand Pharmaceuticals Incorporated Share Price Target
Get share price movements and forecasts by analysts on Ligand Pharmaceuticals Incorporated.
What analysts predicted
18.16%UPSIDE
Target Price
$237.5
Current Price
$194.37
Analyzed by
11 Analysts
Target
$237.50
Ligand Pharmaceuticals Incorporated target price $237.5, a slight upside of 18.16% compared to current price of $194.37. According to 11 analysts rating.
Ligand Pharmaceuticals Incorporated Stock’s Investor Sentiment and Interest
Search interest for Ligand Pharmaceuticals Incorporated Stock has increased by 375% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:375% versus previous 30 day period
Ligand Pharmaceuticals Incorporated Quarterly Profit & Loss
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Annual Profit & Loss
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Quarterly Cash Flow
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Annual Cash Flow
All numbers in Millions USD
Insights on Ligand Pharmaceuticals Incorporated
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -42.45M → 117.27M (in $), with an average increase of 535.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, LGND stock has moved up by 90.6%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 42.81M → 115.46M (in $), with an average increase of 23.0% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 914.2% return, outperforming this stock by 745.7%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 185.2% return, outperforming this stock by 122.5%
About Ligand Pharmaceuticals Incorporated
| Organisation | Ligand Pharmaceuticals Incorporated |
| Headquarters | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
| Industry | Health Technology |
| CEO | Mr. Todd C. Davis Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Ligand Pharmaceuticals Incorporated
Name | Title |
|---|---|
Mr. Octavio Espinoza | Chief Financial Officer |
Dr. Keith Marschke Ph.D. | Senior Vice President of Biology & Scientific Affairs |
Mr. Richard B. Baxter | Senior VP of Investment Operation |
Mr. Scott M. Plesha | CEO of Pelthos Therapeutics |
Mr. Todd C. Davis Ph.D. | CEO & Director |
Mr. Andrew T. Reardon J.D. | Chief Legal Officer & Secretary |
Mr. Paul J. Hadden | Senior Vice President of Investments & Business Development |
Dr. Vincent D. Antle Ph.D. | Senior Vice President of Technical Operations & QA - Capitsol |
Mr. Patrick Lucy | Senior VP & CBO Protein Expression Business |
Dr. Karen R. Reeves M.D. | Senior VP of Investments & Head of Clinical Strategy |
FAQs
What is Ligand Pharmaceuticals Incorporated share price today?
Ligand Pharmaceuticals Incorporated share price today is $194.37 as on . Ligand Pharmaceuticals Incorporated share today touched a day high of $197 and a low of $193.73.
What is the 52 week high and 52 week low for Ligand Pharmaceuticals Incorporated share?
Ligand Pharmaceuticals Incorporated share touched a 52 week high of $212.49 on and a 52 week low of $93.58 on . Ligand Pharmaceuticals Incorporated stock price today i.e. is trending at $194.37,which is 8.53% down from its 52 week high and 107.70% up from its 52 week low.
What is Ligand Pharmaceuticals Incorporated's market capitalisation today?
Ligand Pharmaceuticals Incorporated market capitalisation is $0.00T as on .
How to invest in Ligand Pharmaceuticals Incorporated Stock (LGND) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ligand Pharmaceuticals Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ligand Pharmaceuticals Incorporated Shares that will get you 0.0077 shares as per Ligand Pharmaceuticals Incorporated share price of $194.37 per share as on December 3, 2025 at 10:40 pm IST.
What is the minimum amount required to buy Ligand Pharmaceuticals Incorporated Stock (LGND) from India?
Indian investors can start investing in Ligand Pharmaceuticals Incorporated (LGND) shares with as little as ₹90.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.90 in Ligand Pharmaceuticals Incorporated stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ligand Pharmaceuticals Incorporated share’s latest price of $194.37 as on December 3, 2025 at 10:40 pm IST, you will get 0.0514 shares of Ligand Pharmaceuticals Incorporated. Learn more about
fractional shares .
What are the returns that Ligand Pharmaceuticals Incorporated has given to Indian investors in the last 5 years?
Ligand Pharmaceuticals Incorporated stock has given 128.51% share price returns and 21.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?